^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Bladder Cancer |
| Drug: | Balversa (erdafitinib) (FGFR inhibitor, FGFR1 inhibitor, FGFR4 inhibitor, FGFR2 inhibitor, FGFR3 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Bladder Cancer: Subsequent-Line Systemic Therapy for Locally Advanced or Metastatic Disease (Stage IV)...Preferred regimens…Erdafitinib
